Skip to content

Bovine vs. Human Milk-Based Fortifier Study

Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 2-Bovine vs. Human Milk-Based Fortifier Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02137473
Enrollment
127
Registered
2014-05-13
Start date
2014-08-31
Completion date
2016-03-31
Last updated
2021-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Very Low Birth Weight Infant (<1250g)

Brief summary

Most very low birth weight infants accumulate a nutrient deficit in hospital due to minimal nutrient reserves and elevated nutritional requirements which may contribute to poor outcome. Adding nutrients to human milk improves their nutritional status and growth, but it is unclear if adding bovine protein-based fortifiers as is the current standard of care has some unintended negative consequences to neonates. Infants will be randomized to have their feeds (mother's own milk or pasteurized donor breastmilk) nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier and will be followed in hospital to assess feeding tolerance, growth, gut inflammation, mother's milk and infant gut microbiome, and neonatal morbidity and mortality.

Interventions

OTHERHuman milk-based fortifier
OTHERBovine protein-based fortifier

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Weeks

Inclusion criteria

* \<1250g birth weight * Parent(s) or guardian(s) agree to use donor breastmilk if own mother's milk supply is insufficient

Exclusion criteria

* Infant receives formula or a nutrient fortifier prior to randomization * \>day 14 at the time of enrollment and enteral feeds have not commenced * Infants with major congenital or chromosomal anomalies that could impact growth * Enrollment in another research study affecting nutritional management during the feeding intervention * Reasonable potential that the infant will be transferred to a neonatal intensive care unit where the study protocol will not be continued

Design outcomes

Primary

MeasureTime frameDescription
Feeding tolerance84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes firstPercentage of infants with a significant feeding interruption as defined by days feedings held for ≥12 hours OR feeds reduced by \>50% (ml/kg/d) not due to a clinical procedure or transitioning to the breast

Secondary

MeasureTime frameDescription
Growth84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes firstDaily weight measurements, weekly length measurements, weekly head circumference measurements, z-scores for anthropometric measures

Other

MeasureTime frameDescription
Gut inflammation84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Bayley Scales of Infant and Toddler Development (BSID)-III18-24 months corrected ageCognitive, language and motor development as assessed by the BSID-III
Gut microbiota56 days of age or hospital discharge
Morbidity/mortality composite84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes firstNecrotizing enterocolitis, late onset sepsis, chronic lung disease, severe retinopathy of prematurity, death
Other measures of feeding tolerance84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes firstPercent and number of days of emesis, gastric aspirates \>50% pre-feed volume, abdominal distension (\>2 cm), percentage of infants where enteral feeding was terminated and parenteral nutrition had to be commenced, some assessment of the interruption of feeds, how long it takes to reach full enteral feeds (150 ml/kg/d)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026